CTLT 2018-11-05 0.11% v d 7 5458.8k -26.84% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=CTLT&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=CTLT&ty=c&ta=1&p=d
ZTS 2018-11-01 2.69% v d 1 3634.5k -11.01% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=ZTS&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=ZTS&ty=c&ta=1&p=d
TEVA 2018-11-01 % v d 8 1508.9k -10.48% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=TEVA&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=TEVA&ty=c&ta=1&p=d
ELAN 2018-11-06 1.57% v d None 1470.7k -16.09% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=ELAN&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=ELAN&ty=c&ta=1&p=d
VTRS None 0.61% v d None 1121.5k -24.28% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=VTRS&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=VTRS&ty=c&ta=1&p=d
CGC 2018-11-13 12.64% v d None 908.6k -40.92% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=CGC&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=CGC&ty=c&ta=1&p=d
TLRY 2018-11-27 % v d None 721.8k -21.19% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=TLRY&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=TLRY&ty=c&ta=1&p=d
PRGO 2018-11-08 2.43% v d 5 501.7k -15.33% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=PRGO&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=PRGO&ty=c&ta=1&p=d
EBS 2018-11-01 0.26% v d 8 466.5k -37.07% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=EBS&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=EBS&ty=c&ta=1&p=d
VERU 2018-05-08 -8.33% v d None 458.0k -53.56% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=VERU&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=VERU&ty=c&ta=1&p=d
BHC 2018-11-06 0.70% v d None 360.6k -41.24% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=BHC&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=BHC&ty=c&ta=1&p=d
PCRX 2018-11-14 -1.54% v d 186 344.7k -13.22% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=PCRX&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=PCRX&ty=c&ta=1&p=d
TAK 2020-05-05 -1.12% v d None 311.7k -11.01% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=TAK&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=TAK&ty=c&ta=1&p=d
AMPH 2018-11-14 0.12% v d 70 294.0k -21.15% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=AMPH&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=AMPH&ty=c&ta=1&p=d
IRWD 2018-11-01 -0.37% v d 177 261.8k -10.99% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=IRWD&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=IRWD&ty=c&ta=1&p=d
PLXP 2018-11-08 % v d 196.6k -36.68% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=PLXP&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=PLXP&ty=c&ta=1&p=d
SUPN 2018-11-05 -3.14% v d 7 188.3k -7.04% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=SUPN&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=SUPN&ty=c&ta=1&p=d
AVDL 2018-11-14 0.91% v d 166.6k -68.34% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=AVDL&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=AVDL&ty=c&ta=1&p=d
HROW 2021-11-10 3.00% v d None 160.4k -18.58% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=HROW&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=HROW&ty=c&ta=1&p=d
RDY 2018-10-26 4.37% v d 10 151.0k -12.38% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=RDY&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=RDY&ty=c&ta=1&p=d
ASRT 2018-11-06 % v d None 150.9k -24.73% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=ASRT&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=ASRT&ty=c&ta=1&p=d
XXII 2018-11-08 -1.09% v d 146.7k -28.19% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=XXII&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=XXII&ty=c&ta=1&p=d
TCDA 2018-11-14 % v d None 136.0k -94.48% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=TCDA&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=TCDA&ty=c&ta=1&p=d
HEXO 2021-12-14 % v d None 102.8k -41.56% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=HEXO&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=HEXO&ty=c&ta=1&p=d
COLL 2018-11-14 1.01% v d 2 93.3k -17.31% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=COLL&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=COLL&ty=c&ta=1&p=d
EGRX 2018-11-14 -2.48% v d 7 84.5k -16.53% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=EGRX&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=EGRX&ty=c&ta=1&p=d
EOLS 2018-11-01 -0.35% v d None 78.3k -17.62% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=EOLS&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=EOLS&ty=c&ta=1&p=d
RLMD 2020-05-12 -4.15% v d None 77.2k -79.57% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=RLMD&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=RLMD&ty=c&ta=1&p=d
ANIP 2018-11-01 -0.73% v d 1 75.0k -18.65% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=ANIP&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=ANIP&ty=c&ta=1&p=d
CLVR None % v d None 73.6k -50.26% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=CLVR&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=CLVR&ty=c&ta=1&p=d
GHSI None % v d None 69.6k -29.42% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=GHSI&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=GHSI&ty=c&ta=1&p=d
ENDP 2018-11-08 % v d 67.6k -46.54% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=ENDP&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=ENDP&ty=c&ta=1&p=d
ORGO 2021-11-10 -23.32% v d None 66.8k -19.97% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=ORGO&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=ORGO&ty=c&ta=1&p=d
ACB 2021-02-12 8.79% v d None 65.7k -38.46% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=ACB&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=ACB&ty=c&ta=1&p=d
RDHL 2018-11-12 % v d 58.5k -32.66% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=RDHL&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=RDHL&ty=c&ta=1&p=d
LCI 2018-11-05 % v d 6 53.3k -31.68% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=LCI&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=LCI&ty=c&ta=1&p=d
CRON 2018-11-26 0.81% v d None 52.3k -15.48% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=CRON&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=CRON&ty=c&ta=1&p=d
ATNX 2018-11-08 % v d None 51.3k -54.88% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=ATNX&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=ATNX&ty=c&ta=1&p=d
IMCC None % v d None 51.2k -75.00% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=IMCC&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=IMCC&ty=c&ta=1&p=d
SXTC None % v d None 51.2k -58.77% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=SXTC&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=SXTC&ty=c&ta=1&p=d
PRFX None % v d None 47.2k -51.58% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=PRFX&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=PRFX&ty=c&ta=1&p=d
EVOK 2018-11-13 % v d 44.1k -25.00% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=EVOK&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=EVOK&ty=c&ta=1&p=d
SLDB 2018-11-09 -2.62% v d None 41.1k -32.39% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=SLDB&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=SLDB&ty=c&ta=1&p=d
AMRX 2018-11-07 % v d None 37.3k -14.00% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=AMRX&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=AMRX&ty=c&ta=1&p=d
AGRX 2018-11-05 % v d 36.5k -28.41% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=AGRX&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=AGRX&ty=c&ta=1&p=d
YCBD 2021-02-10 % v d None 34.0k -22.58% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=YCBD&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=YCBD&ty=c&ta=1&p=d
PHGE 2021-11-12 % v d None 33.9k -17.38% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=PHGE&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=PHGE&ty=c&ta=1&p=d
PETQ 2018-11-05 -1.27% v d None 33.7k -16.94% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=PETQ&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=PETQ&ty=c&ta=1&p=d
NEPT 2015-07-21 % v d 31.5k -30.71% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=NEPT&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=NEPT&ty=c&ta=1&p=d
MDVL None % v d None 30.3k -52.60% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=MDVL&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=MDVL&ty=c&ta=1&p=d
TYHT 2018-11-13 % v d 29.6k -41.01% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=TYHT&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=TYHT&ty=c&ta=1&p=d
SNDL 2021-11-12 -2.50% v d None 29.5k -41.47% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=SNDL&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=SNDL&ty=c&ta=1&p=d
ACRX 2018-11-08 % v d 27.7k -22.46% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=ACRX&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=ACRX&ty=c&ta=1&p=d
ZOM 2018-11-08 % v d None 27.0k -35.74% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=ZOM&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=ZOM&ty=c&ta=1&p=d
HAPP None % v d None 25.7k -18.21% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=HAPP&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=HAPP&ty=c&ta=1&p=d
TXMD 2018-11-05 -2.60% v d 25.5k -21.46% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=TXMD&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=TXMD&ty=c&ta=1&p=d
ZYNE 2018-11-13 % v d 23.1k -27.17% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=ZYNE&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=ZYNE&ty=c&ta=1&p=d
FLGC None % v d None 23.0k -41.19% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=FLGC&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=FLGC&ty=c&ta=1&p=d
JUPW None % v d None 22.2k -38.81% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=JUPW&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=JUPW&ty=c&ta=1&p=d
RMTI 2018-11-14 1.34% v d 19.3k -28.57% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=RMTI&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=RMTI&ty=c&ta=1&p=d
DRRX 2018-11-07 % v d 19.2k -15.68% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=DRRX&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=DRRX&ty=c&ta=1&p=d
PAHC 2018-11-05 -0.96% v d 5 18.2k -9.11% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=PAHC&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=PAHC&ty=c&ta=1&p=d
ADMP 2018-11-13 % v d 17.9k -50.96% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=ADMP&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=ADMP&ty=c&ta=1&p=d
SCYX 2018-11-06 % v d 15.7k -25.80% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=SCYX&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=SCYX&ty=c&ta=1&p=d
OGI 2021-01-12 -3.63% v d None 13.2k -14.48% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=OGI&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=OGI&ty=c&ta=1&p=d
CPHI 2017-03-29 % v d 12.8k -31.58% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=CPHI&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=CPHI&ty=c&ta=1&p=d
SNOA 2018-11-08 % v d None 10.2k -23.93% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=SNOA&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=SNOA&ty=c&ta=1&p=d
AMYT None % v d None 9.4k -14.15% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=AMYT&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=AMYT&ty=c&ta=1&p=d
OPTN 2018-11-26 -2.19% v d None 6.4k -33.47% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=OPTN&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=OPTN&ty=c&ta=1&p=d
TARO 2018-11-06 0.66% v d 9 6.2k -8.98% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=TARO&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=TARO&ty=c&ta=1&p=d
PRPH 2017-02-28 -2.17% v d 6.1k -24.71% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=PRPH&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=PRPH&ty=c&ta=1&p=d
REPH 2018-11-08 % v d 38 5.7k -39.67% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=REPH&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=REPH&ty=c&ta=1&p=d
GRVI None % v d None 5.1k -23.09% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=GRVI&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=GRVI&ty=c&ta=1&p=d
INCR 2018-02-27 % v d 13 5.0k -15.24% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=INCR&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=INCR&ty=c&ta=1&p=d
HUGE None % v d None 3.7k -10.80% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=HUGE&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=HUGE&ty=c&ta=1&p=d
CALT None % v d None 3.6k -20.12% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=CALT&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=CALT&ty=c&ta=1&p=d
ALIM 2018-11-07 % v d 1.7k -18.23% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=ALIM&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=ALIM&ty=c&ta=1&p=d
NLTX 2021-11-09 % v d None 1.6k -19.86% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=NLTX&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=NLTX&ty=c&ta=1&p=d
THTX 2020-04-02 % v d None 1.5k -36.02% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=THTX&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=THTX&ty=c&ta=1&p=d
KMDA 2018-11-12 % v d 1.1k -9.83% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=KMDA&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=KMDA&ty=c&ta=1&p=d
RGC 2018-02-08 % v d 4 0.4k -34.17% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=RGC&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=RGC&ty=c&ta=1&p=d
CPIX 2018-11-06 % v d 0.3k -18.49% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=CPIX&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=CPIX&ty=c&ta=1&p=d
QLI None % v d None 0.2k -26.11% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=QLI&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=QLI&ty=c&ta=1&p=d
AERI 2018-11-14 % v d 153 0.0k -21.40% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=AERI&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=AERI&ty=c&ta=1&p=d
KIN 2018-11-06 % v d k -27.79% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=KIN&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=KIN&ty=c&ta=1&p=d
PPD 2021-02-24 % v d None k -21.66% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=PPD&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=PPD&ty=c&ta=1&p=d
ADMS 2018-11-01 % v d 137 k -43.29% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=ADMS&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=ADMS&ty=c&ta=1&p=d
APHA 2021-01-14 % v d None k -35.82% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=APHA&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=APHA&ty=c&ta=1&p=d
FLXN 2018-11-05 % v d 164 k -32.24% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=FLXN&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=FLXN&ty=c&ta=1&p=d
NEOS 2018-11-14 % v d k -25.41% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=NEOS&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=NEOS&ty=c&ta=1&p=d
RDUS 2018-11-01 1.28% v d 170 k -44.30% drug manufacturers - specialty & generic drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=RDUS&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=RDUS&ty=c&ta=1&p=d
TLGT 2018-11-05 % v d k -39.56% drug manufacturers - specialty & generic
http://finviz.com/quote.ashx?t=TLGT&ty=c&ta=0&p=m http://finviz.com/quote.ashx?t=TLGT&ty=c&ta=1&p=d